Skip to content

Randomized clinical trial comparing primary anterior cruciate ligament reconstruction with hamstring grafts with and without the bioinductive implant Biobrace®

Randomized double-blind clinical trial comparing the functional outcomes of patients undergoing primary anterior cruciate ligament reconstruction with hamstring grafts with and without the use of intra-articular reinforcement with the bioinductive implant Biobrace®

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-2w8s4r9
Enrollment
Unknown
Registered
2025-10-16
Start date
2025-11-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anterior Cruciate Ligament injuries

Interventions

This is a randomized, controlled, double-blind, two-arm clinical trial. A total of 88 participants will be allocated to the groups using a block randomization system. Experimental group: 44 individual

Sponsors

Instituto de Ortopedia e Traumatologia do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
Lead Sponsor
Instituto de Ortopedia e Traumatologia do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
Collaborator

Eligibility

Age
16 Years to 50 Years

Inclusion criteria

Inclusion criteria: Patients with unilateral anterior cruciate ligament injury with surgical indication, with or without associated meniscal lesions; Patients with skeletal maturity; Both genders; Aged between 16 and 50 years

Exclusion criteria

Exclusion criteria: Presence of other associated ligament injuries requiring reconstruction; Patients with mechanical axis deviation of the lower limb requiring corrective osteotomy; Presence of chondral lesions requiring repair; Presence of associated fractures or other pathological conditions of the lower limbs

Design outcomes

Primary

MeasureTime frame
It is expected to observe a mean difference of at least 1 mm between the groups (with and without the use of the Biobrace® bioinductive implant) in the differences of anterior tibial translation between operated and non-operated sides, as assessed by the KT-1000 arthrometer test after a 2-year postoperative follow-up

Secondary

MeasureTime frame
It is expected to observe similar or better functional outcomes in anterior cruciate ligament reconstruction with the bioinductive Biobrace® implant compared to reconstruction without the implant, as assessed by the International Knee Documentation Committee (IKDC) and Lysholm Knee Scoring Scale at 6 months, 1 year, and 2 years of postoperative follow-up;It is expected to observe lower failure rates of anterior cruciate ligament reconstruction with the bioinductive Biobrace® implant compared to anterior cruciate ligament reconstruction without the implant, after 6 months, 1 year, and 2 years of postoperative follow-up;It’s expected to find lower or similar residual rotational knee instability, as assessed by the pivot shift clinical test, in anterior cruciate ligament reconstruction with the bioinductive Biobrace® implant compared to reconstruction without the implant, after 6 months, 1 year, and 2 years of postoperative follow-up;It is expected to find a shorter or similar graft maturation time in anterior cruciate ligament reconstructions with the bioinductive Biobrace® implant compared to reconstructions without the implant, as assessed by the graft signal-to-noise quotient (SNQ) on postoperative magnetic resonance imaging at 6 months, 1 year, and 2 years

Countries

Brazil

Contacts

Public ContactCamilo Helito

Instituto de Ortopedia e Traumatologia do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo

camilo_helito@yahoo.com.br+55(11)99776-1249

Outcome results

None listed

Source: REBEC (via WHO ICTRP)